Controversial Role of the Immune Checkpoint OX40L Expression on Platelets in Breast Cancer Progression

5Citations
Citations of this article
23Readers
Mendeley users who have this article in their library.
Get full text

Abstract

In conventional T cells, OX40 has been identified as a major costimulating receptor augmenting survival and clonal expansion of effector and memory T cell populations. In regulatory T cells, (Treg) OX40 signaling suppresses cellular activity and differentiation. However, clinical trials investigating OX40 agonists to enhance anti-tumor immunity, showed only limited success so far. Here we show that platelets from breast cancer patients express relevant levels of OX40L and platelet OX40L (pOX40L) inversely correlates with platelet-expressed immune checkpoint molecules GITRL (pGITRL) and TACI (pTACI). While high expression of pOX40L correlates with T and NK cell activation, elevated pOX40L levels identify patients with higher tumor grades, the occurrence of metastases, and shorter recurrence-free survival (RFS). Of note, OX40 mRNA levels in breast cancer correlate with enhanced expression of anti-apoptotic, immune-suppressive, and tumor-promoting mRNA gene signatures. Our data suggest that OX40L on platelets might play counteracting roles in cancer and anti-tumor immunity. Since pOX40L reflects disease relapse better than the routinely used predictive markers CA15-3, CEA, and LDH, it could serve as a novel biomarker for refractory disease in breast cancer.

References Powered by Scopus

Enhancement of antitumor immunity by CTLA-4 blockade

3160Citations
N/AReaders
Get full text

Contribution of platelets to tumour metastasis

1361Citations
N/AReaders
Get full text

Prognostic and predictive value of tumor-infiltrating lymphocytes in a phase III randomized adjuvant breast cancer trial in node-positive breast cancer comparing the addition of docetaxel to doxorubicin with doxorubicin-based chemotherapy: BIG 02-98

1336Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Interactions between Platelets and Tumor Microenvironment Components in Ovarian Cancer and Their Implications for Treatment and Clinical Outcomes

6Citations
N/AReaders
Get full text

OX40/OX40 ligand and its role in precision immune oncology

5Citations
N/AReaders
Get full text

Cross-talk between disulfidptosis and immune check point genes defines the tumor microenvironment for the prediction of prognosis and immunotherapies in glioblastoma

1Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Rittig, S. M., Lutz, M. S., Clar, K. L., Zhou, Y., Kropp, K. N., Koch, A., … Hinterleitner, C. (2022). Controversial Role of the Immune Checkpoint OX40L Expression on Platelets in Breast Cancer Progression. Frontiers in Oncology, 12. https://doi.org/10.3389/fonc.2022.917834

Readers' Seniority

Tooltip

Researcher 2

50%

Professor / Associate Prof. 1

25%

PhD / Post grad / Masters / Doc 1

25%

Readers' Discipline

Tooltip

Pharmacology, Toxicology and Pharmaceut... 2

33%

Biochemistry, Genetics and Molecular Bi... 2

33%

Nursing and Health Professions 1

17%

Neuroscience 1

17%

Save time finding and organizing research with Mendeley

Sign up for free